He S - Search Results

1

PAX3 knockdown in metastatic melanoma cell lines does not reduce MITF expression.

He S, Li CG, Slobbe L, Glover A, Marshall E, Baguley BC, Eccles MR. He S, et al. Melanoma Res. 2011 Feb;21(1):24-34. doi: 10.1097/CMR.0b013e328341c7e0. Melanoma Res. 2011. PMID: 21164369

2

Transfection of melanoma cells with antisense PAX3 oligonucleotides additively complements cisplatin-induced cytotoxicity.

He SJ, Stevens G, Braithwaite AW, Eccles MR. He SJ, et al. Mol Cancer Ther. 2005 Jun;4(6):996-1003. doi: 10.1158/1535-7163.MCT-04-0252. Mol Cancer Ther. 2005. PMID: 15956257

3

A gene expression signature of invasive potential in metastatic melanoma cells.

Jeffs AR, Glover AC, Slobbe LJ, Wang L, He S, Hazlett JA, Awasthi A, Woolley AG, Marshall ES, Joseph WR, Print CG, Baguley BC, Eccles MR. Jeffs AR, et al. Among authors: he s. PLoS One. 2009 Dec 24;4(12):e8461. doi: 10.1371/journal.pone.0008461. PLoS One. 2009. PMID: 20041153 Free PMC article.

4

MITF and PAX3 Play Distinct Roles in Melanoma Cell Migration; Outline of a "Genetic Switch" Theory Involving MITF and PAX3 in Proliferative and Invasive Phenotypes of Melanoma.

Eccles MR, He S, Ahn A, Slobbe LJ, Jeffs AR, Yoon HS, Baguley BC. Eccles MR, et al. Among authors: he s. Front Oncol. 2013 Sep 11;3:229. doi: 10.3389/fonc.2013.00229. Front Oncol. 2013. PMID: 24062982 Free PMC article. Review.

5

A PANorama of PAX genes in cancer and development.

Robson EJ, He SJ, Eccles MR. Robson EJ, et al. Nat Rev Cancer. 2006 Jan;6(1):52-62. doi: 10.1038/nrc1778. Nat Rev Cancer. 2006. PMID: 16397527 Review.

6

PAX3 Is extensively expressed in benign and malignant tissues of the melanocytic lineage in humans.

He S, Yoon HS, Suh BJ, Eccles MR. He S, et al. J Invest Dermatol. 2010 May;130(5):1465-8. doi: 10.1038/jid.2009.434. Epub 2010 Jan 28. J Invest Dermatol. 2010. PMID: 20107488 Free article. No abstract available.

7

PAX genes in development and disease: the role of PAX2 in urogenital tract development.

Eccles MR, He S, Legge M, Kumar R, Fox J, Zhou C, French M, Tsai RW. Eccles MR, et al. Among authors: he s. Int J Dev Biol. 2002;46(4):535-44. Int J Dev Biol. 2002. PMID: 12141441 Review.

8

PAX3 is expressed in the stromal compartment of the developing kidney and in Wilms tumors with myogenic phenotype.

Hueber PA, Fukuzawa R, Elkares R, Chu L, Blumentkrantz M, He SJ, Anaka MR, Reeve AE, Eccles M, Jabado N, Iglesias DM, Goodyer PR. Hueber PA, et al. Pediatr Dev Pathol. 2009 Sep-Oct;12(5):347-54. doi: 10.2350/08-05-0466.1. Pediatr Dev Pathol. 2009. PMID: 18666806

9

WT1 is a modifier of the Pax2 mutant phenotype: cooperation and interaction between WT1 and Pax2.

Discenza MT, He S, Lee TH, Chu LL, Bolon B, Goodyer P, Eccles M, Pelletier J. Discenza MT, et al. Among authors: he s. Oncogene. 2003 Nov 6;22(50):8145-55. doi: 10.1038/sj.onc.1206997. Oncogene. 2003. PMID: 14603255

10

Metastatic sites of baseline as predictors in recurrent or metastatic nasopharyngeal carinoma treated with PD-L1 inhibitor: a secondary analysis of multicenter, single-arm, phase II study (KL-A167).

Li Y, Min Y, Wei Z, Liu Z, Pei Y, Yang Y, Gao K, Song G, Xu S, He S, Ge J, Qing Y, Wei Y, Ai P, Chen Y, Peng X. Li Y, et al. Among authors: he s. Cancer Immunol Immunother. 2025 Jan 3;74(2):72. doi: 10.1007/s00262-024-03905-0. Cancer Immunol Immunother. 2025. PMID: 39751901 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,856 results

Search Page

Filters